Comparison of Nodal Target Volume Definition in Breast Cancer Radiation Therapy According to RTOG Versus ESTRO Atlases: A Practical Review From the TransAtlantic Radiation Oncology Network (TRONE).


Journal

International journal of radiation oncology, biology, physics
ISSN: 1879-355X
Titre abrégé: Int J Radiat Oncol Biol Phys
Pays: United States
ID NLM: 7603616

Informations de publication

Date de publication:
01 07 2020
Historique:
received: 15 12 2019
revised: 02 04 2020
accepted: 08 04 2020
pubmed: 26 4 2020
medline: 16 2 2021
entrez: 26 4 2020
Statut: ppublish

Résumé

Regional nodal irradiation has gained interest in recent years with the publication of several important randomized trials and the availability of more conformal techniques. Target volume delineation represents a critical step in the radiation planning process. Adequate coverage of the microscopic tumor spread to regional lymph nodes must be weighed against exposure of critical structures such as the heart and lungs. Among available guidelines for delineating the clinical target volume for the breast/chest wall and regional nodes, the Radiation Therapy Oncology Group and European Society for Radiotherapy and Oncology guidelines are the most widely used internationally. These guidelines have been formulated based on anatomic boundaries of areas historically covered in 2-dimensional field-based radiation therapy but have not been validated by patterns-of-failure studies. In recent years, an important body of data has emerged from mapping studies documenting patterns of local and regional recurrence. We aim to review, discuss, and compare contouring guidelines for breast cancer radiation therapy in the context of contemporary data on locoregional relapse to improve their implementation in modern practice.

Identifiants

pubmed: 32334035
pii: S0360-3016(20)31030-0
doi: 10.1016/j.ijrobp.2020.04.012
pii:
doi:

Types de publication

Comparative Study Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

437-448

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Gokoulakrichenane Loganadane (G)

Henri Mondor Breast Center and Department of Radiation Oncology, APHP; University of Paris-Est Creteil (UPEC) and INSERM Unit 955 - Team 21. Creteil, France.

Pauline T Truong (PT)

Department of Radiation Oncology, British Columbia Cancer Agency and University of British Columbia, Vancouver, Canada.

Alphonse G Taghian (AG)

Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.

Dušanka Tešanović (D)

Medical Faculty of University of Novi Sad, Novi Sad and Oncology Institute of Vojvodina, Sremska Kamenica, Serbia.

Mawei Jiang (M)

University Hospital of Xinhua and Jiao Tong University, Shanghai, China.

Fady Geara (F)

Department of Radiation Oncology, American University of Beirut, Beirut, Lebanon.

Meena S Moran (MS)

Department of Radiation Oncology, Yale University School of Medicine, Smilow Cancer Center, New Haven, Connecticut.

Yazid Belkacemi (Y)

Henri Mondor Breast Center and Department of Radiation Oncology, APHP; University of Paris-Est Creteil (UPEC) and INSERM Unit 955 - Team 21. Creteil, France. Electronic address: yazid.belkacemi@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH